EUVIMEDEUVIMED entdecken
Open Access

Deletion of Carboxypeptidase E in β-Cells Disrupts Proinsulin Processing but Does Not Lead to Spontaneous Development of Diabetes in Mice

Yi-Chun Chen iD, Austin J Taylor iD, James M Fulcher iD, Adam C Swensen iD, Xiao-Qing Dai, Mitsuhiro Komba iD, Kenzie L C Wrightson iD, Kenny Fok, Annette E Patterson, Ramon I Klein Geltink iD, Patrick E MacDonald iD, Wei-Jun Qian iD und 1 weitere

Diabetes · 2023

DOI: 10.2337/db22-0945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Yi-Chun Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Carboxypeptidase H, Diabetes Mellitus, Type 2, Hyperglycemia, Insulin-Secreting Cells. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, Canadian Institutes of Health and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carboxypeptidase E (CPE) facilitates the conversion of prohormones into mature hormones and is highly expressed in multiple neuroendocrine tissues. Carriers of CPE mutations have elevated plasma proinsulin and develop severe obesity and hyperglycemia. We aimed to determine whether loss of Cpe in pancreatic β-cells disrupts proinsulin processing and accelerates development of diabetes and obesity in mice. Pancreatic β-cell–specific Cpe knockout mice (βCpeKO; Cpefl/fl x Ins1Cre/+) lack mature insulin granules and have elevated proinsulin in plasma; however, glucose-and KCl-stimulated insulin secretion in βCpeKO islets remained intact. High-fat diet–fed βCpeKO mice showed weight gain and glucose tolerance comparable with those of Wt littermates. Notably, β-cell area was increased in chow-fed βCpeKO mice and β-cell replication was elevated in βCpeKO islets. Transcriptomic analysis of βCpeKO β-cells revealed elevated glycolysis and Hif1α-target gene expression. On high glucose challenge, β-cells from βCpeKO mice showed reduced mitochondrial membrane potential, increased reactive oxygen species, reduced MafA, and elevated Aldh1a3 transcript levels. Following multiple low-dose streptozotocin injections, βCpeKO mice had accelerated development of hyperglycemia with reduced β-cell insulin and Glut2 expression. These findings suggest that Cpe and proper proinsulin processing are critical in maintaining β-cell function during the development of hyperglycemia. Article Highlights Carboxypeptidase E (Cpe) is an enzyme that removes the carboxy-terminal arginine and lysine residues from peptide precursors. Mutations in CPE lead to obesity and type 2 diabetes in humans, and whole-body Cpe knockout or mutant mice are obese and hyperglycemic and fail to convert proinsulin to insulin. We show that β-cell–specific Cpe deletion in mice (βCpeKO) does not lead to the development of obesity or hyperglycemia, even after prolonged high-fat diet treatment. However, β-cell proliferation rate and β-cell area are increased, and the development of hyperglycemia induced by multiple low-dose streptozotocin injections is accelerated in βCpeKO mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carboxypeptidase HDiabetes Mellitus, Type 2HyperglycemiaInsulin-Secreting CellsIslets of LangerhansAnimalsMiceGlucoseInsulinMice, KnockoutObesityProinsulinStreptozocin

Substanzen

Carboxypeptidase HGlucoseInsulinProinsulinStreptozocin

Autor:innen und Institutionen

  • Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Integrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA.
  • Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada.
  • Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Yi-Chun Chen, Austin J Taylor, James M Fulcher, Adam C Swensen, Mitsuhiro Komba, Kenzie L C Wrightson, Ramon I Klein Geltink, Patrick E MacDonald, Wei-Jun Qian, C Bruce Verchere

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • Canadian Institutes of Health and Research
  • DOE
  • Juvenile Diabetes Research Federation
  • National Institutes of Health

Zitieren

APA

Chen, Y. C., Taylor, A. J., Fulcher, J. M., Swensen, A. C., Dai, X. Q., Komba, M., Wrightson, K. L. C., Fok, K., Patterson, A. E., Klein Geltink, R. I., MacDonald, P. E., Qian, W. J., & Verchere, C. B. (2023). Deletion of Carboxypeptidase E in β-Cells Disrupts Proinsulin Processing but Does Not Lead to Spontaneous Development of Diabetes in Mice. Diabetes. https://doi.org/10.2337/db22-0945

Vancouver

Chen YC, Taylor AJ, Fulcher JM, Swensen AC, Dai XQ, Komba M, et al. Deletion of Carboxypeptidase E in β-Cells Disrupts Proinsulin Processing but Does Not Lead to Spontaneous Development of Diabetes in Mice. Diabetes. 2023. doi:10.2337/db22-0945

BibTeX
@article{Chen2023,
  author = {Chen, Yi-Chun and Taylor, Austin J and Fulcher, James M and Swensen, Adam C and Dai, Xiao-Qing and Komba, Mitsuhiro and Wrightson, Kenzie L C and Fok, Kenny and Patterson, Annette E and Klein Geltink, Ramon I and MacDonald, Patrick E and Qian, Wei-Jun and Verchere, C Bruce},
  title = {Deletion of Carboxypeptidase E in β-Cells Disrupts Proinsulin Processing but Does Not Lead to Spontaneous Development of Diabetes in Mice},
  journal = {Diabetes},
  year = {2023},
  doi = {10.2337/db22-0945}
}
Kostenlos starten →